PTX3 and graft versus host disease: The example is coming from a study where patients with haemato-oncological diseases who underwent stem cell transplantation (HSCT) were evaluated to explore the potential of the long pentraxin 3 (PTX3) as a prognostic marker of Acute Graft-versus-Host Disease (GvHD) [1].